Loading
A phase 2 trial of Scalp cooling in Breast cancer, run by Hospital San Carlos, Madrid, completed.
Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling is a phase 2 interventional study registered as NCT00515762 by Hospital San Carlos, Madrid, with 150 participants recorded, started 2007-05 and reaching its primary completion in 2010-06. Interventions recorded: elasto-gel cap. Conditions recorded: Alopecia, Breast Cancer.
Linked to the technology Scalp cooling because the registry's title names it ("scalp cooling") and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types) and the tag pipeline.
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types) and the tag pipeline.
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types).
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types).
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/